Clinical Trial

the Clinical Outcome of Empagliflozin in Pediatric Heart Failure Patients

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
the study to investigate the efficacy of empagiflozin in pediatric heart failure
Trial Details
NCT Number NCT07692256
Lead Sponsor Ain Shams University
Conditions Heart Failure
Enrollment 60 participants
Start Date 2025-12-01
Primary Completion 2026-12-01 (estimated)
Study Completion 2027-02-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-09